Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic variability in response to clopidogrel therapy: clinical implications.

× No keyword cloud information.

9 in total

1. Fresh from the pipeline. Ticagrelor.

Authors: Kurt Huber; Bashar Hamad; Peter Kirkpatrick
Journal: Nat Rev Drug Discov Date: 2011-04 Impact factor: 84.694

2. Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometry.

Authors: Zhe-Yi Hu; S Casey Laizure; Vanessa L Herring; Robert B Parker
Journal: Rapid Commun Mass Spectrom Date: 2014-06-15 Impact factor: 2.419

Review 3. Genetic determinations of variable responsiveness to clopidogrel and implications for neurointerventional procedures.

Authors: Ruth Colley; Bernard Yan
Journal: Interv Neurol Date: 2012-05

Review 4. Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?

Authors: Hannes F Alber; Kurt Huber; Otmar Pachinger; Matthias Frick
Journal: Wien Klin Wochenschr Date: 2011-08-03 Impact factor: 1.704

5. The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel.

Authors: Alf-Aage R Pettersen; Harald Arnesen; Trine B Opstad; Ingebjorg Seljeflot
Journal: Thromb J Date: 2011-03-22

6. Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance.

Authors: Jingyu Chen; Michael Zhiyan Wang
Journal: Lett Drug Des Discov Date: 2016-03 Impact factor: 1.150

7. Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndrome.

Authors: María Henar García-Lagunar; Luciano Consuegra-Sánchez; Pablo Conesa-Zamora; Javier Ruiz-Cosano; Federico Soria-Arcos; Luis García de Guadiana; Pedro Cano Vivar; Juan Antonio Castillo-Moreno; Antonio Melgarejo-Moreno
Journal: Anatol J Cardiol Date: 2017-02-01 Impact factor: 1.596

Review 8. Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls.

Authors: Max-Paul Winter; Marek Koziński; Jacek Kubica; Daniel Aradi; Jolanta M Siller-Matula
Journal: Postepy Kardiol Interwencyjnej Date: 2015-01-12 Impact factor: 1.426

9. Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole: A Prospective, Randomized, Controlled Trial.

Authors: Jian-Rong Zhang; Di-Qing Wang; Jun Du; Guang-Su Qu; Jian-Lin Du; Song-Bai Deng; Ya-Jie Liu; Jin-Xi Cai; Qiang She
Journal: Medicine (Baltimore) Date: 2015-12 Impact factor: 1.817

9 in total